A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Lucas Colombo et al. ECG na doença coronariana aguda. Métodos gráficos em cardiologia: guia essencial na prática clínica, 2024Tradução . . Acesso em: 10 set. 2024.
APA
Godoy, L. C., Soares, B. M. A. F., Furtado, R. H. de M., Baracioli, L. M., & Nicolau, J. C. (2024). ECG na doença coronariana aguda. Métodos gráficos em cardiologia: guia essencial na prática clínica.
NLM
Godoy LC, Soares BMAF, Furtado RH de M, Baracioli LM, Nicolau JC. ECG na doença coronariana aguda. Métodos gráficos em cardiologia: guia essencial na prática clínica. 2024 ;[citado 2024 set. 10 ]
Vancouver
Godoy LC, Soares BMAF, Furtado RH de M, Baracioli LM, Nicolau JC. ECG na doença coronariana aguda. Métodos gráficos em cardiologia: guia essencial na prática clínica. 2024 ;[citado 2024 set. 10 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNO, Tatiana C et al. Prognosis related to reperfusion therapy post-acute coronary syndrome in secondary care: long-term survival analysis in the ERICO study. Arquivos Brasileiros de Cardiologia, v. 120, n. 5, p. e20220849, 2023Tradução . . Disponível em: https://doi.org/10.36660/abc.20220849. Acesso em: 10 set. 2024.
APA
Bruno, T. C., Bittencourt, M. S., Quidim, A. V. L., Santos, I. de S., Lotufo, P. A., Benseñor, I. J. M., & Goulart, A. C. (2023). Prognosis related to reperfusion therapy post-acute coronary syndrome in secondary care: long-term survival analysis in the ERICO study. Arquivos Brasileiros de Cardiologia, 120( 5), e20220849. doi:10.36660/abc.20220849
NLM
Bruno TC, Bittencourt MS, Quidim AVL, Santos I de S, Lotufo PA, Benseñor IJM, Goulart AC. Prognosis related to reperfusion therapy post-acute coronary syndrome in secondary care: long-term survival analysis in the ERICO study [Internet]. Arquivos Brasileiros de Cardiologia. 2023 ; 120( 5): e20220849.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20220849
Vancouver
Bruno TC, Bittencourt MS, Quidim AVL, Santos I de S, Lotufo PA, Benseñor IJM, Goulart AC. Prognosis related to reperfusion therapy post-acute coronary syndrome in secondary care: long-term survival analysis in the ERICO study [Internet]. Arquivos Brasileiros de Cardiologia. 2023 ; 120( 5): e20220849.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20220849
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Remo Holanda de Mendonça et al. Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction. Esc heart failure, v. 10, n. 1, p. 442-452, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57358. Acesso em: 10 set. 2024.
APA
Furtado, R. H. de M., Juliasz, M. G., Chiu, F. Y. J., Bastos, L. B. C., Dalçóquio, T. F., Lima, F. G., et al. (2023). Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction. Esc heart failure, 10( 1), 442-452. doi:10.1002/ehf2.14201
NLM
Furtado RH de M, Juliasz MG, Chiu FYJ, Bastos LBC, Dalçóquio TF, Lima FG, Melo RR, Pereira CAC, Bertolin AJ, Genestreti PRR, Nicolau JC. Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction [Internet]. Esc heart failure. 2023 ; 10( 1): 442-452.[citado 2024 set. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57358
Vancouver
Furtado RH de M, Juliasz MG, Chiu FYJ, Bastos LBC, Dalçóquio TF, Lima FG, Melo RR, Pereira CAC, Bertolin AJ, Genestreti PRR, Nicolau JC. Long-term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction [Internet]. Esc heart failure. 2023 ; 10( 1): 442-452.[citado 2024 set. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57358
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONCALVES JUNIOR, Jucier e SHINJO, Samuel Katsuyuki. Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review. Clinical rheumatology, v. 42, n. 11, p. 2943-2950, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57355. Acesso em: 10 set. 2024.
APA
Goncalves Junior, J., & Shinjo, S. K. (2023). Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review. Clinical rheumatology, 42( 11), 2943-2950. doi:10.1007/s10067-023-06633-5
NLM
Goncalves Junior J, Shinjo SK. Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review [Internet]. Clinical rheumatology. 2023 ; 42( 11): 2943-2950.[citado 2024 set. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57355
Vancouver
Goncalves Junior J, Shinjo SK. Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review [Internet]. Clinical rheumatology. 2023 ; 42( 11): 2943-2950.[citado 2024 set. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57355
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA, Letícia de Carvalho et al. Redução da ansiedade relacionada ao cateterismo cardíaco: aceitabilidade de intervenção complexa. Acta Paulista de Enfermagem, v. 36, 2023Tradução . . Disponível em: http://dx.doi.org/10.37689/acta-ape/2023AO007433. Acesso em: 10 set. 2024.
APA
Batista, L. de C., Nóbrega, M. do P. S. de S., Salvetti, M. de G., & Butcher, R. de C. G. e S. (2023). Redução da ansiedade relacionada ao cateterismo cardíaco: aceitabilidade de intervenção complexa. Acta Paulista de Enfermagem, 36. doi:10.37689/acta-ape/2023AO007433
NLM
Batista L de C, Nóbrega M do PS de S, Salvetti M de G, Butcher R de CG e S. Redução da ansiedade relacionada ao cateterismo cardíaco: aceitabilidade de intervenção complexa [Internet]. Acta Paulista de Enfermagem. 2023 ; 36[citado 2024 set. 10 ] Available from: http://dx.doi.org/10.37689/acta-ape/2023AO007433
Vancouver
Batista L de C, Nóbrega M do PS de S, Salvetti M de G, Butcher R de CG e S. Redução da ansiedade relacionada ao cateterismo cardíaco: aceitabilidade de intervenção complexa [Internet]. Acta Paulista de Enfermagem. 2023 ; 36[citado 2024 set. 10 ] Available from: http://dx.doi.org/10.37689/acta-ape/2023AO007433
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEOCADIO, Paola Caroline Lacerda et al. Lower paraoxonase 1 paraoxonase activity is associated with a worse prognosis in patients with non-ST-segment elevation myocardial infarction in long-term follow-up. Coronary artery disease, v. 33, n. 7, p. 515-522, 2022Tradução . . Disponível em: https://doi.org/10.1097/MCA.0000000000001181. Acesso em: 10 set. 2024.
APA
Leocadio, P. C. L., Goulart, A. C., Santos, I. S., Lotufo, P. A., Benseñor, I. J. M., & Alvarez-Leite, J. I. (2022). Lower paraoxonase 1 paraoxonase activity is associated with a worse prognosis in patients with non-ST-segment elevation myocardial infarction in long-term follow-up. Coronary artery disease, 33( 7), 515-522. doi:10.1097/MCA.0000000000001181
NLM
Leocadio PCL, Goulart AC, Santos IS, Lotufo PA, Benseñor IJM, Alvarez-Leite JI. Lower paraoxonase 1 paraoxonase activity is associated with a worse prognosis in patients with non-ST-segment elevation myocardial infarction in long-term follow-up [Internet]. Coronary artery disease. 2022 ; 33( 7): 515-522.[citado 2024 set. 10 ] Available from: https://doi.org/10.1097/MCA.0000000000001181
Vancouver
Leocadio PCL, Goulart AC, Santos IS, Lotufo PA, Benseñor IJM, Alvarez-Leite JI. Lower paraoxonase 1 paraoxonase activity is associated with a worse prognosis in patients with non-ST-segment elevation myocardial infarction in long-term follow-up [Internet]. Coronary artery disease. 2022 ; 33( 7): 515-522.[citado 2024 set. 10 ] Available from: https://doi.org/10.1097/MCA.0000000000001181
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Rafael Rahal Guaragna et al. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, v. 4, n. 5, p. 1514–1527, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsptsci.1c00080. Acesso em: 10 set. 2024.
APA
Machado, R. R. G., Glaser, T., Araujo, D. B., Petiz, L. L., Durigon, D. B. L. de O., Durigon, G. S., et al. (2021). Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, 4( 5), 1514–1527. doi:10.1021/acsptsci.1c00080
NLM
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 set. 10 ] Available from: https://doi.org/10.1021/acsptsci.1c00080
Vancouver
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 set. 10 ] Available from: https://doi.org/10.1021/acsptsci.1c00080
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOHNSON, Camille Alardis Hunte et al. Knowledge, attitudes, and beliefs about acute coronary syndrome among patients with type 2 diabetes. Revista Latino-Americana de Enfermagem, v. 29, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1590/1518-8345.5435.3503. Acesso em: 10 set. 2024.
APA
Johnson, C. A. H., Pitta, N. C., Dessotte, C. A. M., Dantas, R. A. S., & Rossi, L. A. (2021). Knowledge, attitudes, and beliefs about acute coronary syndrome among patients with type 2 diabetes. Revista Latino-Americana de Enfermagem, 29, 1-11. doi:10.1590/1518-8345.5435.3503
NLM
Johnson CAH, Pitta NC, Dessotte CAM, Dantas RAS, Rossi LA. Knowledge, attitudes, and beliefs about acute coronary syndrome among patients with type 2 diabetes [Internet]. Revista Latino-Americana de Enfermagem. 2021 ; 29 1-11.[citado 2024 set. 10 ] Available from: https://doi.org/10.1590/1518-8345.5435.3503
Vancouver
Johnson CAH, Pitta NC, Dessotte CAM, Dantas RAS, Rossi LA. Knowledge, attitudes, and beliefs about acute coronary syndrome among patients with type 2 diabetes [Internet]. Revista Latino-Americana de Enfermagem. 2021 ; 29 1-11.[citado 2024 set. 10 ] Available from: https://doi.org/10.1590/1518-8345.5435.3503
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Andreia Alexandra Machado et al. Moderate coffee consumption is associated with lower risk of mortality in prior Acute Coronary Syndrome patients: a prospective analysis in the ERICO cohort. International Journal of Food Sciences and Nutrition (online), v. 72, n. 6, p. 794-804, 2021Tradução . . Disponível em: https://doi.org/10.1080/09637486.2020.1862069. Acesso em: 10 set. 2024.
APA
Miranda, A. A. M., Goulart, A. C., Bensenor, I. M., Lotufo, P. A., & Marchioni, D. M. L. (2021). Moderate coffee consumption is associated with lower risk of mortality in prior Acute Coronary Syndrome patients: a prospective analysis in the ERICO cohort. International Journal of Food Sciences and Nutrition (online), 72( 6), 794-804. doi:10.1080/09637486.2020.1862069
NLM
Miranda AAM, Goulart AC, Bensenor IM, Lotufo PA, Marchioni DML. Moderate coffee consumption is associated with lower risk of mortality in prior Acute Coronary Syndrome patients: a prospective analysis in the ERICO cohort [Internet]. International Journal of Food Sciences and Nutrition (online). 2021 ;72( 6): 794-804.[citado 2024 set. 10 ] Available from: https://doi.org/10.1080/09637486.2020.1862069
Vancouver
Miranda AAM, Goulart AC, Bensenor IM, Lotufo PA, Marchioni DML. Moderate coffee consumption is associated with lower risk of mortality in prior Acute Coronary Syndrome patients: a prospective analysis in the ERICO cohort [Internet]. International Journal of Food Sciences and Nutrition (online). 2021 ;72( 6): 794-804.[citado 2024 set. 10 ] Available from: https://doi.org/10.1080/09637486.2020.1862069
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEOCÁDIO, Paola et al. High serum netrin-1 and IL-1β in elderly females with ACS: worse prognosis in 2-years follow-up. Arquivos Brasileiros de Cardiologia, v. 114, n. may-ju 2020, p. 507-514, 2020Tradução . . Disponível em: https://doi.org/10.36660/abc.20190035. Acesso em: 10 set. 2024.
APA
Leocádio, P., Menta, P., Dias, M., Fraga, J., Goulart, A. C., Santos, I. de S., et al. (2020). High serum netrin-1 and IL-1β in elderly females with ACS: worse prognosis in 2-years follow-up. Arquivos Brasileiros de Cardiologia, 114( may-ju 2020), 507-514. doi:10.36660/abc.20190035
NLM
Leocádio P, Menta P, Dias M, Fraga J, Goulart AC, Santos I de S, Lotufo PA, Benseñor IJM, Alvarez-Leite J. High serum netrin-1 and IL-1β in elderly females with ACS: worse prognosis in 2-years follow-up [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 114( may-ju 2020): 507-514.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20190035
Vancouver
Leocádio P, Menta P, Dias M, Fraga J, Goulart AC, Santos I de S, Lotufo PA, Benseñor IJM, Alvarez-Leite J. High serum netrin-1 and IL-1β in elderly females with ACS: worse prognosis in 2-years follow-up [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 114( may-ju 2020): 507-514.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20190035
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UCHOA, Ricardo B e CARAMELLI, Bruno. Troponin I as a mortality marker after lung resection surgery - a prospective cohort study. Bmc anesthesiology, v. 20, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12871-020-01037-3. Acesso em: 10 set. 2024.
APA
Uchoa, R. B., & Caramelli, B. (2020). Troponin I as a mortality marker after lung resection surgery - a prospective cohort study. Bmc anesthesiology, 20( 1). doi:10.1186/s12871-020-01037-3
NLM
Uchoa RB, Caramelli B. Troponin I as a mortality marker after lung resection surgery - a prospective cohort study [Internet]. Bmc anesthesiology. 2020 ; 20( 1):[citado 2024 set. 10 ] Available from: https://doi.org/10.1186/s12871-020-01037-3
Vancouver
Uchoa RB, Caramelli B. Troponin I as a mortality marker after lung resection surgery - a prospective cohort study [Internet]. Bmc anesthesiology. 2020 ; 20( 1):[citado 2024 set. 10 ] Available from: https://doi.org/10.1186/s12871-020-01037-3
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FELÍCIO, Andressa Cristina de Souza et al. Versão brasileira do Toronto pain management inventory – acute coronary syndrome. REME - Revista Mineira de Enfermagem, v. 24, 2020Tradução . . Disponível em: https://doi.org/10.5935/1415-2762.20200057. Acesso em: 10 set. 2024.
APA
Felício, A. C. de S., Ferretti-Rebustini, R. E. de L., Murakami, B. M., Coelho, F. U. de A., Lopes, C. T., O'Keefe-McCarthy, S., & Santos, E. R. dos. (2020). Versão brasileira do Toronto pain management inventory – acute coronary syndrome. REME - Revista Mineira de Enfermagem, 24. doi:10.5935/1415-2762.20200057
NLM
Felício AC de S, Ferretti-Rebustini RE de L, Murakami BM, Coelho FU de A, Lopes CT, O'Keefe-McCarthy S, Santos ER dos. Versão brasileira do Toronto pain management inventory – acute coronary syndrome [Internet]. REME - Revista Mineira de Enfermagem. 2020 ; 24[citado 2024 set. 10 ] Available from: https://doi.org/10.5935/1415-2762.20200057
Vancouver
Felício AC de S, Ferretti-Rebustini RE de L, Murakami BM, Coelho FU de A, Lopes CT, O'Keefe-McCarthy S, Santos ER dos. Versão brasileira do Toronto pain management inventory – acute coronary syndrome [Internet]. REME - Revista Mineira de Enfermagem. 2020 ; 24[citado 2024 set. 10 ] Available from: https://doi.org/10.5935/1415-2762.20200057
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEOCADIO, Paola et al. Níveis elevados de netrina-1 e IL-1beta em mulheres idosas com SCA: pior prognóstico no acompanhamento de dois anos. Arquivos Brasileiros de Cardiologia, v. 114, n. 3, p. 507-514, 2020Tradução . . Disponível em: https://doi.org/10.36660/abc.20190035. Acesso em: 10 set. 2024.
APA
Leocadio, P., Menta, P., Dias, M., Fraga, J., Goulart, A., Santos, I. de S., et al. (2020). Níveis elevados de netrina-1 e IL-1beta em mulheres idosas com SCA: pior prognóstico no acompanhamento de dois anos. Arquivos Brasileiros de Cardiologia, 114( 3), 507-514. doi:10.36660/abc.20190035
NLM
Leocadio P, Menta P, Dias M, Fraga J, Goulart A, Santos I de S, Lotufo PA, Benseñor IJM, Alvarez-leite J. Níveis elevados de netrina-1 e IL-1beta em mulheres idosas com SCA: pior prognóstico no acompanhamento de dois anos [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 114( 3): 507-514.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20190035
Vancouver
Leocadio P, Menta P, Dias M, Fraga J, Goulart A, Santos I de S, Lotufo PA, Benseñor IJM, Alvarez-leite J. Níveis elevados de netrina-1 e IL-1beta em mulheres idosas com SCA: pior prognóstico no acompanhamento de dois anos [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 114( 3): 507-514.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20190035
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Rafael C O et al. Frequency and reasons for non-administration and suspension of drugs during an acute coronary syndrome event: the ERICO study. Arquivos Brasileiros de Cardiologia, v. no 2020, n. 5, p. 830-839, 2020Tradução . . Disponível em: https://doi.org/10.36660/abc.20190317. Acesso em: 10 set. 2024.
APA
Santos, R. C. O., Benseñor, I. J. M., Goulart, A. C., Lotufo, P. A., & Santos, I. de S. (2020). Frequency and reasons for non-administration and suspension of drugs during an acute coronary syndrome event: the ERICO study. Arquivos Brasileiros de Cardiologia, no 2020( 5), 830-839. doi:10.36660/abc.20190317
NLM
Santos RCO, Benseñor IJM, Goulart AC, Lotufo PA, Santos I de S. Frequency and reasons for non-administration and suspension of drugs during an acute coronary syndrome event: the ERICO study [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; no 2020( 5): 830-839.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20190317
Vancouver
Santos RCO, Benseñor IJM, Goulart AC, Lotufo PA, Santos I de S. Frequency and reasons for non-administration and suspension of drugs during an acute coronary syndrome event: the ERICO study [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; no 2020( 5): 830-839.[citado 2024 set. 10 ] Available from: https://doi.org/10.36660/abc.20190317
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTNER, Vera A et al. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. Journal of the american college of cardiology, v. 75, n. 2, p. 133-144, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2019.10.057. Acesso em: 10 set. 2024.
APA
Bittner, V. A., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Edelberg, J. M., et al. (2020). Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. Journal of the american college of cardiology, 75( 2), 133-144. doi:10.1016/j.jacc.2019.10.057
NLM
Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Nicolau JC. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome [Internet]. Journal of the american college of cardiology. 2020 ; 75( 2): 133-144.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.10.057
Vancouver
Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Nicolau JC. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome [Internet]. Journal of the american college of cardiology. 2020 ; 75( 2): 133-144.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.10.057
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Remo H. M et al. Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography. Journal of the american college of cardiology, v. 75, n. 3, p. 289-300, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2019.11.035. Acesso em: 10 set. 2024.
APA
Furtado, R. H. M., Nicolau, J. C., Guo, J., Im, K., White, J. A., Sabatine, M. S., et al. (2020). Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography. Journal of the american college of cardiology, 75( 3), 289-300. doi:10.1016/j.jacc.2019.11.035
NLM
Furtado RHM, Nicolau JC, Guo J, Im K, White JA, Sabatine MS, Newby LK, Giugliano RP. Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography [Internet]. Journal of the american college of cardiology. 2020 ; 75( 3): 289-300.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.11.035
Vancouver
Furtado RHM, Nicolau JC, Guo J, Im K, White JA, Sabatine MS, Newby LK, Giugliano RP. Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography [Internet]. Journal of the american college of cardiology. 2020 ; 75( 3): 289-300.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.11.035
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOODMAN, Shaun G et al. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery. Journal of the american college of cardiology, v. 74, n. 9, p. 1177-1186, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2019.07.015. Acesso em: 10 set. 2024.
APA
Goodman, S. G., Aylward, P. E., Szarek, M., Chumburidze, V., Bhatt, D. L., Bittner, V. A., et al. (2019). Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery. Journal of the american college of cardiology, 74( 9), 1177-1186. doi:10.1016/j.jacc.2019.07.015
NLM
Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Nicolau JC. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery [Internet]. Journal of the american college of cardiology. 2019 ; 74( 9): 1177-1186.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.07.015
Vancouver
Goodman SG, Aylward PE, Szarek M, Chumburidze V, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Hanotin C, Nicolau JC. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery [Internet]. Journal of the american college of cardiology. 2019 ; 74( 9): 1177-1186.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.07.015
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCHI, Francesco et al. Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial. Journal of the american heart association, v. 8, n. 6, 2019Tradução . . Disponível em: https://doi.org/10.1161/JAHA.118.011139. Acesso em: 10 set. 2024.
APA
Franchi, F., James, S. K., Lakic, T. G., Budaj, A. J., Cornel, J. H., Katus, H. A., et al. (2019). Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial. Journal of the american heart association, 8( 6). doi:10.1161/JAHA.118.011139
NLM
Franchi F, James SK, Lakic TG, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Nicolau JC. Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial [Internet]. Journal of the american heart association. 2019 ; 8( 6):[citado 2024 set. 10 ] Available from: https://doi.org/10.1161/JAHA.118.011139
Vancouver
Franchi F, James SK, Lakic TG, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Nicolau JC. Impact of diabetes mellitus and chronic kidney disease on cardiovascular outcomes and platelet P2Y(12) receptor antagonist effects in patients with acute coronary syndromes: insights from the PLATO trial [Internet]. Journal of the american heart association. 2019 ; 8( 6):[citado 2024 set. 10 ] Available from: https://doi.org/10.1161/JAHA.118.011139
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUKEMA, J. Wouter et al. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial. Journal of the american college of cardiology, v. 74, n. 9, p. 1167-1176, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2019.03.013. Acesso em: 10 set. 2024.
APA
Jukema, J. W., Szarek, M., Zijlstra, L. E., Silva, H. A. de, Bhatt, D. L., Bittner, V. A., et al. (2019). Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial. Journal of the american college of cardiology, 74( 9), 1167-1176. doi:10.1016/j.jacc.2019.03.013
NLM
Jukema JW, Szarek M, Zijlstra LE, Silva HA de, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Nicolau JC. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial [Internet]. Journal of the american college of cardiology. 2019 ; 74( 9): 1167-1176.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.03.013
Vancouver
Jukema JW, Szarek M, Zijlstra LE, Silva HA de, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Nicolau JC. Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial [Internet]. Journal of the american college of cardiology. 2019 ; 74( 9): 1167-1176.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/j.jacc.2019.03.013
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAY, Kausik K et al. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet diabetes & endocrinology, v. 7, n. 8, p. 618-628, 2019Tradução . . Disponível em: https://doi.org/10.1016/S2213-8587(19)30158-5. Acesso em: 10 set. 2024.
APA
Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-dinet, M., Bhatt, D. L., Bittner, V. A., et al. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet diabetes & endocrinology, 7( 8), 618-628. doi:10.1016/S2213-8587(19)30158-5
NLM
Ray KK, Colhoun HM, Szarek M, Baccara-dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Nicolau JC. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial [Internet]. Lancet diabetes & endocrinology. 2019 ; 7( 8): 618-628.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/S2213-8587(19)30158-5
Vancouver
Ray KK, Colhoun HM, Szarek M, Baccara-dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Nicolau JC. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial [Internet]. Lancet diabetes & endocrinology. 2019 ; 7( 8): 618-628.[citado 2024 set. 10 ] Available from: https://doi.org/10.1016/S2213-8587(19)30158-5